Charlie Sheen recently opened up about his infamous departure from Two and a Half Men. At the height of his career, there was no television star bigger than Sheen. He made nearly $2 million per episode of the comedy series. However, things came crashing down for the star as he wound up fired from the show.
Sheen has now released a new memoir, The Book of Sheen. In it, he delved into the rather bizarre reason that led to his shocking actions and exit from the show.
Charlie Sheen says a testosterone cream messed up his ‘state of mind’ while filming Two and a Half Men
Charlie Sheen discussed his firing from Two and a Half Men in detail in his memoir. Most already know that Sheen infamously criticized the series’ creator, Chuck Lorre, leading to him being fired from the show.
The 60-year-old Golden Globe winner explained that his notorious media meltdown was caused by the use of a legal testosterone cream that he was using to get into better shape. The actor wrote, “It didn’t go as planned… What I chose not to quit was the testosterone cream that I was slathering on in mind-altering gobs like a f**ken Pond’s commercial. After all, it was ‘legal.’ I’d been using it to get my body back into shape, not knowing that at the same time I was being shape-shifted.”
Sheen claimed that he quit all the other illicit substances that he had used in the past. However, he continued the use of this cream. “That drug is known to metabolize into the identical psych profile an anabolic steroid will produce,” Sheen explained. “Anyone who bore witness to the raging demon I melded with will hopefully glean some clarity for what my state of mind was up against,” he added.
He further claimed that the substance could have had a positive impact if used correctly. “I’ve heard great things about the drug when used responsibly. But let’s keep it real — drugs and responsible are two words I never made of habit of cramming into the same sentence,” the actor wrote in his memoir.
The Book of Sheen is now available for purchase at most major outlets.
Originally reported by Sourav Chakraborty on Comingsoon.